About BenevolentAI SA
Ticker
info
BAI
Trading on
info
AS
ISIN
info
LU2355630455
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
-
Headquarters
info
4-8 Maple Street, London, undefined, United Kingdom, W1T 5HD
Employees
info
180
Website
info
benevolent.com
BenevolentAI S.A. operates as a clinical-stage artificial intelligence (AI) enabled drug discovery and development company. Its Benevolent platform integrates AI and science to uncover and develop drugs for complex diseases. The company's development pipeline includes BEN-8744, an oral phosphodiesterase 10 (PDE10) inhibitor under phase 1 study for the treatment of Ulcerative Colitis; BEN-28010, an oral brain penetrant CHK1 inhibitor under preclinical study for the treatment of Glioblastoma Multiforme; BEN-34712, a preclinical candidate for the potential treatment of ALS; and various candidates for the treatment of fibrosis and Parkinson's disease. It has collaboration agreements with AstraZeneca and Merck to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.
Metrics
BasicAdvanced
Market cap
info
€11.2M
P/E ratio
info
-
EPS
info
-€0.64
Dividend Yield
info
0.00%
Beta
info
0.86
Forward P/E ratio
info
0
EBIDTA
info
€-62.8M
Ex dividend date
info
-
Price & volume
Market cap
info
€11.2M
Average daily volume
info
0.3M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
€0.00
Dividend yield
info
0.00%
Forward dividend per share
info
€0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
2.31
Price to book
info
0.11
Earnings
EPS
info
-€0.64
EPS estimate (current quarter)
info
€0.00
EPS estimate (next quarter)
info
€0.00
EBITDA
info
€-62.8M
Revenues (TTM)
info
€4.9M
Revenues per share (TTM)
info
€0.04
Technicals
Beta
info
0.86
52-week High
info
€0.91
52-week Low
info
€0.07
50-day moving average
info
€0.25
200-day moving average
info
€0.55
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
53.04%
ROA (TTM)
info
32.76%
Profit margin
info
0.00%
Gross profit margin
info
€2.1M
Operating margin
info
1,111.19%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
46.50%
Share stats
Outstanding Shares
info
122M
Float
info
114M
Insiders %
info
25.89%
Institutions %
info
17.98%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a BenevolentAI SA share?
Collapse

BenevolentAI SA shares are currently traded for undefined per share.

How many shares does BenevolentAI SA have?
Collapse

BenevolentAI SA currently has 122M shares.

Does BenevolentAI SA pay dividends?
Collapse

No, BenevolentAI SA doesn't pay dividends.

What is BenevolentAI SA 52 week high?
Collapse

BenevolentAI SA 52 week high is €0.91.

What is BenevolentAI SA 52 week low?
Collapse

BenevolentAI SA 52 week low is €0.07.

What is the 200-day moving average of BenevolentAI SA?
Collapse

BenevolentAI SA 200-day moving average is €0.55.

Who is BenevolentAI SA CEO?
Collapse

The CEO of BenevolentAI SA is -.

How many employees BenevolentAI SA has?
Collapse

BenevolentAI SA has 180 employees.

What is the market cap of BenevolentAI SA?
Collapse

The market cap of BenevolentAI SA is €11.2M.

What is the P/E of BenevolentAI SA?
Collapse

The current P/E of BenevolentAI SA is null.

What is the EPS of BenevolentAI SA?
Collapse

The EPS of BenevolentAI SA is -€0.64.

What is the PEG Ratio of BenevolentAI SA?
Collapse

The PEG Ratio of BenevolentAI SA is null.